Emergent Biodefense Operations Lansing LLC – FDA 483, Apr 12, 2016
An FDA inspection of Emergent BioDefense Operations Lansing LLC, a licensed biological manufacturer in Lansing, Michigan, revealed several deficiencies in their manufacturing and quality control processes for Anthrax Vaccine Adsorbed. Observations included inadequate investigations into mold contamination and out-of-specification potency results, lack of established reject limits and reinspection criteria for visual inspection, and insufficient environmental monitoring. The findings indicate a need for improved controls and adherence to established procedures to ensure product quality and safety.
- Inspection date
- April 12, 2016
- Product type
- biologics
ID · 5507cc83-bd28-405f-bd89-2a8b07648040
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.